dinutuximab beta
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
dinutuximab beta
Jul 24, 2024, 13:28 |
Blog
Ruzanna Papyan: The significant role of anti-GD2 therapy in the treatment of relapsed or refractory neuroblastoma
Ruzanna Papyan shared a post on LinkedIn about a recent paper by Patricia Raiser et al., commenting:…
Jul 10, 2024, 05:18 |
Insight
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
APEIRON Biologics AG (“APEIRON”), a leading Austrian biotech company, today announced that its shareholders have…
May 27, 2024, 12:01 |
Drugs
Ruzanna Papyan: I suggest delving into the critical management of adverse events associated with dinutuximab beta
Ruzanna Papyan shared on LinkedIn: "Week 3 of the Global Access To Anti GD2 Campaign:…
All:
3
Posts:
1 - 100
43 Posts Not To Miss From ESMO24 Day 2
45 Posts not to miss from ESMO24 Day 1
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube